21 Assessments Completed
| Publication | Date | Overall Assessment | Actions |
|---|---|---|---|
Transformative tales: The role of story videos on children's reasoning about transgender identities 10.1111/bjdp.12503 | 16 Apr 2026 | Some concerns | View |
Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial 10.1016/j.ajog.2021.04.234 | 2 Mar 2026 | Serious concerns | View |
Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial 10.1007/s00394-018-1760-8 | 2 Mar 2026 | Some concerns | View |
High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial 10.1016/j.fertnstert.2014.02.021 | 2 Mar 2026 | No concerns | View |
Effects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial 10.3390/nu17071246 | 26 Feb 2026 | Serious concerns | View |
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial 10.1136/bmj-2024-081557 | 16 Nov 2025 | Some concerns | View |
Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial 10.1136/bmj-2025-084418 | 16 Nov 2025 | Some concerns | View |
A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial 10.1136/bmj-2024-082765 | 16 Nov 2025 | Some concerns | View |
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial 10.1136/bmj-2025-084314 | 16 Nov 2025 | Some concerns | View |
Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trial 10.1136/bmj-2025-084539 | 16 Nov 2025 | Some concerns | View |
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial 10.1136/bmj-2025-084290 | 16 Nov 2025 | Some concerns | View |
Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke | 13 Nov 2025 | Serious concerns | View |
RETRACTED ARTICLE: Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety 10.1007/s00404-015-3767-1 | 12 Nov 2025 | Serious concerns | View |
Closed‐loop automated oxygen control in late preterm and term, ventilated infants: A randomised controlled trial 10.1111/apa.17549 | 12 Nov 2025 | Some concerns | View |
Calcium-Vitamin D co-supplementation affects metabolic profiles, but not pregnancy outcomes, in healthy pregnant women 10.4103/2008-7802.177895 | 12 Nov 2025 | Serious concerns | View |
Transformative tales: The role of story videos on children's reasoning about transgender identities 10.1111/bjdp.12503 | 12 Nov 2025 | Some concerns | View |
The effects of vitamin D, K and calcium co-supplementation on carotid intima-media thickness and metabolic status in overweight type 2 diabetic patients with CHD 10.1017/s0007114516001847 | 12 Nov 2025 | Serious concerns | View |
Effects of synbiotic food consumption on glycemic status and serum hs-CRP in pregnant women: a randomized controlled clinical trial | 12 Nov 2025 | Serious concerns | View |
Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial 10.1186/s13063-025-08916-5 | 10 Nov 2025 | Serious concerns | View |
Cell therapy for acute myocardial infarction: Requiescat in Pace 10.1093/eurheartj/ehaa802 | 10 Nov 2025 | Serious concerns | View |
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) 10.1136/bmj-2024-083382 | 31 Oct 2025 | No concerns | View |